Capricor Therapeutics, Inc. (CAPR)


Capricor Therapeutics, Inc. (CAPR)

$3.30 USD

0.13 (-3.79%)

Updated Jun 17 6:55pm

Add CAPR to Watchlist
Sign Up

Overall POWR Rating

Sign Up for Ratings

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 322 in Biotech

See all “A” rated Strong Buy stocks

CAPR Daily Price Range
CAPR 52-Week Price Range
Learn More About POWR Ratings

CAPR News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All CAPR News

Capricor Therapeutics, Inc. (CAPR) Company Bio

Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company was founded in 2005 and is based in Beverly Hills, California.

CAPR Stock Chart More Charts

CAPR Price/Volume Stats

Current price $3.30
Prev. close $3.43
Day low $2.92
Day high $3.77
50-day MA $4.19
200-day MA $6.50
52-week high $15.80
52-week low $2.53
Volume 58,600
Avg. volume 35,578
Dividend yield N/A
Market Cap 11.44M

CAPR Social Stream

Loading social stream, please wait...

View Full CAPR Social Stream

CAPR Returns

1-mo 3.12%
3-mo -40.16%
6-mo -36.54%
1-year -76.43%
3-year -92.60%
5-year -92.16%
YTD -19.51%
2018 -74.05%
2017 -40.60%
2016 -13.36%
2015 -18.13%
2014 15.38%

Top Stories View All

Microsoft (MSFT) announces it will continue to sell Huawei laptops online

Good growth stocks to buy in June: Five Below (FIVE), Stitch Fix (SFIX), and lululemon athletica (LULU)

FedEx (FDX) and Dollar General (DG) announce partnership, for drop off and pickup of packages

BMO upgrades Keurig Dr Pepper (KDP) to outperform

Domino's Pizza (DPZ) will test unmanned delivery vehicles

View All Top Stories
Page generated in 0.426 seconds.